This bill would amend the Anti-Terrorism Act of 1987 to designate the Muslim Brotherhood as a terrorist organization and prohibit its operations within the United States. It would require the President to designate the Muslim Brotherhood as a foreign terrorist organization under immigration law and impose new visa restrictions, including immediate revocation of current visas, for individuals identified as members. The bill mandates annual reports from the Secretary of State identifying Muslim Brotherhood branches worldwide and determining which should be designated as terrorist organizations under existing laws. These provisions would directly affect Muslim Brotherhood members, branches, and affiliated organizations seeking entry to or operating within the United States.
This bill requires Medicare Advantage and prescription drug plans to reimburse the Department of Veterans Affairs (VA) for health care services provided to veterans enrolled in those plans, including outpatient care, prescription drugs, and inpatient services. It establishes a new process for the VA to recover costs from Medicare plans, requiring these plans to respond to reimbursement claims within 45 days and face penalties for non-compliance, including triple damages for willful violations. The law modifies existing VA authority to recover costs for non-service-connected disabilities by clarifying recovery procedures and requiring Medicare plans to coordinate benefits with VA care. The provisions apply to Medicare plan years beginning January 1, 2026, and directly affect Medicare Advantage organizations and prescription drug plan sponsors that serve veterans. This policy change ensures veterans receive full benefits without double payments by requiring Medicare plans to reimburse the VA for services they cover.
HRES 921 is a symbolic resolution recognizing the 30th anniversary of the Dayton Peace Accords, signed on December 14, 1995, which ended the Bosnian War. It commemorates the agreement that halted violence, established Bosnia and Herzegovina’s sovereignty, and created a framework for peacebuilding. The resolution acknowledges Dayton, Ohio’s role in hosting the negotiations and honors the Bosnian-American diaspora, while reaffirming U.S. support for Bosnia’s democratic development and EU/NATO integration efforts. It contains no new policy requirements or funding, serving solely as a statement of historical recognition and ongoing diplomatic commitment.
HRES 918 is a ceremonial resolution honoring Akron, Ohio, on the 200th anniversary of its founding (December 6, 1825). It recognizes the city’s historical contributions to American culture, including its role in the Underground Railroad, the 1851 Women’s Convention where Sojourner Truth delivered her "Ain’t I a Woman?" speech, its "Rubber Capital" industry legacy, and its status as the birthplace of notable figures in sports, music, and science. The resolution has no policy provisions or direct impact on residents, government programs, or funding - it is purely symbolic commemoration. The House formally "honors and commemorates" these contributions and encourages Akron to continue its legacy of advocating for justice.
HRES 856 is a non-binding resolution expressing the House of Representatives' view that the U.S. Department of Agriculture (USDA) should use its existing contingency funds and interchange authority to fund the Supplemental Nutrition Assistance Program (SNAP) for November 2025. The resolution cites that the USDA holds over $5 billion in contingency funds set aside for emergencies and has legal authority under the Department of Agriculture Organic Act to transfer funds between nutrition programs to maintain SNAP benefits. This would directly support approximately 42 million people relying on SNAP, including 16 million children, 8 million seniors, 4 million people with disabilities, and 1.2 million veterans, preventing disruption during a potential funding gap. The resolution does not create new law but urges the administration to use existing resources to ensure continued food assistance.
S 3302, the Mikaela Naylon Give Kids a Chance Act of 2025, requires drug manufacturers developing cancer treatments to conduct pediatric-focused research for certain drugs targeting pediatric cancer mechanisms. It amends FDA drug approval processes to mandate molecularly targeted pediatric cancer investigations for drugs with new active ingredients or specific approved combinations, ensuring studies address dosing, safety, and efficacy for children. The bill also extends priority review vouchers (which expedite FDA reviews) for rare pediatric disease treatments until 2030 and mandates GAO studies to evaluate how effectively these incentives spur new pediatric cancer drug development. These changes apply to new drug applications submitted three years after the law's enactment, with reports due to Congress at 6, 8, and 10 years.
This bill requires the Veterans Health Administration to expand its existing informed consent directive (currently covering long-term opioid therapy) to include written consent for five additional medication categories: antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics. It directly affects Veterans receiving VA care for these specific medications, mandating that providers obtain written informed consent before prescribing them. The key mechanism is updating VA Directive 1005 to explicitly apply to these new medication types, ensuring consistent consent processes across VA treatment. This change applies only to VA healthcare settings, not to civilian medical practices.
The Artificial Intelligence Civil Rights Act of 2025 requires developers and deployers of AI systems that make decisions affecting "consequential actions" (such as employment, housing, healthcare, education, and credit) to conduct pre-deployment evaluations and annual impact assessments by independent auditors. The bill mandates transparency requirements including clear disclosures to individuals about how AI is used in decision-making, establishes a right to human alternatives for significant AI-driven decisions, and prohibits discrimination based on protected characteristics like race, gender, or disability. It creates enforcement mechanisms through the Federal Trade Commission, state attorneys general, and private lawsuits, with penalties including civil penalties of up to 4% of annual revenue. The act also requires developers to provide explanations for AI-driven decisions and sets standards for data collection to prevent harm and ensure fairness in critical life areas.
The Kidd's Stuttering Act requires Medicaid and CHIP to screen children aged 2-6 for stuttering and speech fluency during routine well-child visits starting January 1, 2027. It also mandates that Medicaid and CHIP cover specified speech therapy services for childhood stuttering (defined as "specified speech therapy services") with coverage rules no more restrictive than those for other speech disorders like language delays. The bill ensures these services include telehealth options and applies to all states administering Medicaid or CHIP. This directly affects children with stuttering who qualify for Medicaid or CHIP, aiming to improve early detection and access to treatment.
The CLEAR Act of 2025 prevents repeated lawsuits challenging the same energy project after a final court ruling. It establishes a "single action rule": once a court rules on an authorization for an energy project (like a permit for a wind farm or pipeline), no further lawsuits about that project can be filed in federal or state courts, regardless of the party or type of claim. Exceptions include legal actions about operational violations after the project begins producing energy or enforcement actions by government agencies. The bill also limits courts to remanding approvals for correction within 180 days and requires lawsuits to be filed within 150 days of public agency action, unless a shorter timeframe applies.
HR 6361, the Ban AI Denials in Medicare Act, prohibits the U.S. Department of Health and Human Services from implementing or testing Medicare models that use artificial intelligence for prior authorization of covered services under traditional Medicare. Specifically, it blocks the existing WISeR model (described in a 2025 federal notice) and prevents future models from using AI to deny coverage for Medicare Part A or Part B services. This bill directly affects Medicare beneficiaries and healthcare providers who would otherwise face AI-driven coverage decisions. The key mechanism is an amendment to the Social Security Act, explicitly banning the use of AI in prior authorization systems within Medicare's innovation models.
This bill establishes comprehensive name, image, and likeness (NIL) rights for college athletes, prohibiting institutions from restricting athletes' ability to earn compensation for their personal branding or taking adverse action against them for doing so. It requires transparent NIL agreements for compensation over $600, including specific details about services, compensation amounts, and termination terms. The bill also amends immigration laws to better accommodate international student athletes participating in college sports and updates regulations governing sports agents. Additionally, it establishes a Commission to study college athletics governance, focusing on collective bargaining, revenue sharing, and Title IX compliance, while expanding disclosure requirements for colleges regarding athletics revenue and expenses.
